Syndrome: Pneumonia, community acquired - inpatient, ICU, non-pseudomonal
Primary Therapy(s):
- (Ceftriaxone 2 gm IV qd or Amp/sulbactam 3 gm IV q6) + (Azithromycin 500 mg qd or Resp quinolone)
Alternate Therapy(s):
- Resp quinolone + Aztreonam
Comments: Add Vancomycin (or linezolid) for MRSA risk
Guideline Index Guideline Table
2nd generation cephalosporins--Cefuroxime, Cefpodoxime
Respiratory quionlones--Levofloxacin, Moxifloxacin
Respiratory quionlones--Levofloxacin, Moxifloxacin